{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:31:52Z","timestamp":1793039512917,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014980","name":"Wannan Medical College","doi-asserted-by":"publisher","award":["gxyq2020026"],"award-info":[{"award-number":["gxyq2020026"]}],"id":[{"id":"10.13039\/501100014980","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014980","name":"Wannan Medical College","doi-asserted-by":"publisher","award":["WK2022Z07"],"award-info":[{"award-number":["WK2022Z07"]}],"id":[{"id":"10.13039\/501100014980","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004921","name":"Shanghai Jiao Tong University","doi-asserted-by":"publisher","award":["2022YFC2407003"],"award-info":[{"award-number":["2022YFC2407003"]}],"id":[{"id":"10.13039\/501100004921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004921","name":"Shanghai Jiao Tong University","doi-asserted-by":"publisher","award":["YG2022QN015"],"award-info":[{"award-number":["YG2022QN015"]}],"id":[{"id":"10.13039\/501100004921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.biomaterials.2025.123596","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T21:57:53Z","timestamp":1754344673000},"page":"123596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Hydroxyl-augmented gold nanorods via lactone ring-opening alleviate cisplatin nephrotoxicity through Nrf2 activation"],"prefix":"10.1016","volume":"325","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0549-829X","authenticated-orcid":false,"given":"Chunyan","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueming","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7632-0201","authenticated-orcid":false,"given":"Ying","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biomaterials.2025.123596_bib1","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.annonc.2024.10.009","article-title":"Time to rethink platinum choices in the era of immunotherapy in lung cancer","volume":"36","author":"Harris","year":"2025","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123596_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12943-023-01917-5","article-title":"N6-methyladenosine-modified circPLPP4 sustains cisplatin resistance in ovarian cancer cells via PIK3R1 upregulation","volume":"23","author":"Li","year":"2024","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123596_bib3","first-page":"404","article-title":"Treatment of muscle-invasive and advanced bladder cancer in 2020","volume":"70","author":"Patel","year":"2020","journal-title":"CA Cancer J. Clin."},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123596_bib4","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1038\/s41591-023-02568-1","article-title":"Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial","volume":"29","author":"Galsky","year":"2023","journal-title":"Nat. Med."},{"issue":"10474","key":"10.1016\/j.biomaterials.2025.123596_bib5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(24)02385-7","article-title":"Acute kidney injury","volume":"405","author":"Ostermann","year":"2025","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123596_bib6","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41581-018-0052-0","article-title":"Global epidemiology and outcomes of acute kidney injury","volume":"14","author":"Hoste","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123596_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41568-020-00308-y","article-title":"The rediscovery of platinum-based cancer therapy","volume":"21","author":"Rottenberg","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2025.123596_bib8","article-title":"Hypokalemia, hypomagnesemia, and hyponatremia are associated with acute kidney injury in patients treated with cisplatin","volume":"40","author":"Pinard","year":"2024","journal-title":"J. Oncol. Pharm. Pract."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123596_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41581-022-00631-7","article-title":"Cisplatin nephrotoxicity: new insights and therapeutic implications","volume":"19","author":"Tang","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"issue":"7954","key":"10.1016\/j.biomaterials.2025.123596_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/d41586-023-00803-w","article-title":"Preventing kidney injuries in hospital","volume":"615","author":"Eisenstein","year":"2023","journal-title":"Nature"},{"issue":"43","key":"10.1016\/j.biomaterials.2025.123596_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202404753","article-title":"Mitochondrial dysfunction-evoked DHODH acetylation is involved in renal cell ferroptosis during cisplatin-induced acute kidney injury","volume":"11","author":"Liang","year":"2024","journal-title":"Adv. Sci."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123596_bib12","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.kint.2016.10.011","article-title":"Pyruvate dehydrogenase kinase 4 deficiency attenuates cisplatin-induced acute kidney injury","volume":"91","author":"Oh","year":"2017","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123596_bib13","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1038\/s41467-021-21714-2","article-title":"Catalytic activity tunable ceria nanoparticles prevent chemotherapy-induced acute kidney injury without interference with chemotherapeutics","volume":"12","author":"Weng","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2025.123596_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2025.102685","article-title":"Engineered renal-targeting nanozyme achieves sequential treatment of AKI through ROS clearance and immune modulation","volume":"62","author":"Wang","year":"2025","journal-title":"Nano Today"},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123596_bib15","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/15548627.2022.2084862","article-title":"Mitochondria ROS and mitophagy in acute kidney injury","volume":"19","author":"Su","year":"2023","journal-title":"Autophagy"},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123596_bib16","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1016\/j.ekir.2024.07.020","article-title":"N-acetylcysteine in kidney disease: molecular mechanisms, pharmacokinetics, and clinical effectiveness","volume":"9","author":"Hern\u00e1ndez-Cruz","year":"2024","journal-title":"Kidney Int. Rep."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123596_bib17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/15548627.2023.2252265","article-title":"Melatonin attenuates sepsis-induced acute kidney injury by promoting mitophagy through SIRT3-mediated TFAM deacetylation","volume":"20","author":"Deng","year":"2024","journal-title":"Autophagy"},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123596_bib18","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/s41551-018-0317-8","article-title":"DNA origami nanostructures can exhibit preferential renal uptake and alleviate acute kidney injury","volume":"2","author":"Jiang","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.biomaterials.2025.123596_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2025.216570","article-title":"Harnessing the power of nanoagents in acute kidney injury: a versatile platform for imaging and treatment","volume":"533","author":"Liu","year":"2025","journal-title":"Coord. Chem. Rev."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123596_bib20","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1039\/D3CS00793F","article-title":"Plasmonic silver and gold nanoparticles: shape- and structure-modulated plasmonic functionality for point-of-caring sensing, bioimaging and medical therapy","volume":"53","author":"Hang","year":"2024","journal-title":"Chem. Soc. Rev."},{"issue":"12","key":"10.1016\/j.biomaterials.2025.123596_bib21","article-title":"Reprogramming the tumor microenvironment through second-near-infrared-window photothermal genome editing of PD-L1 mediated by supramolecular gold nanorods for enhanced cancer immunotherapy","volume":"33","author":"Tang","year":"2021","journal-title":"Adv. Mater."},{"issue":"47","key":"10.1016\/j.biomaterials.2025.123596_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202412473","article-title":"Seed-mediated growth and advanced characterization of chiral gold nanorods","volume":"36","author":"Ni","year":"2024","journal-title":"Adv. Mater."},{"issue":"13","key":"10.1016\/j.biomaterials.2025.123596_bib23","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1039\/D1CS00933H","article-title":"Recent development of gold(I) and gold(III) complexes as therapeutic agents for cancer diseases","volume":"51","author":"Lu","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"21","key":"10.1016\/j.biomaterials.2025.123596_bib24","doi-asserted-by":"crossref","first-page":"13342","DOI":"10.1021\/acs.chemrev.1c00422","article-title":"Gold nanorods: the most versatile plasmonic nanoparticles","volume":"121","author":"Zheng","year":"2021","journal-title":"Chem. Rev."},{"issue":"25","key":"10.1016\/j.biomaterials.2025.123596_bib25","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1002\/adma.201400238","article-title":"Nano-gold as artificial enzymes: hidden talents","volume":"26","author":"Lin","year":"2014","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2025.123596_bib26","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jconrel.2022.08.001","article-title":"Stimuli-responsive liposomal nanoformulations in cancer therapy: pre-clinical & clinical approaches","volume":"351","author":"Ashrafizadeh","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2025.123596_bib27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2020.06.022","article-title":"Recent advancements in liposome technology","volume":"156","author":"Filipczak","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"32","key":"10.1016\/j.biomaterials.2025.123596_bib28","doi-asserted-by":"crossref","first-page":"9603","DOI":"10.1002\/anie.201702620","article-title":"Reversible stabilization of vesicles: redox-responsive polymer nanocontainers for intracellular delivery","volume":"56","author":"de Vries","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123596_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202300387","article-title":"Surface ligand engineering ruthenium nanozyme superior to horseradish peroxidase for enhanced immunoassay","volume":"36","author":"Fan","year":"2024","journal-title":"Adv. Mater."},{"issue":"16","key":"10.1016\/j.biomaterials.2025.123596_bib30","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1021\/acs.accounts.3c00255","article-title":"Interfacing nanomaterials with biology through ligand engineering","volume":"56","author":"Gupta","year":"2023","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.biomaterials.2025.123596_bib31","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.addr.2017.10.001","article-title":"Engineering nanomaterials to overcome the mucosal barrier by modulating surface properties","volume":"124","author":"Wu","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2025.123596_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2022.214785","article-title":"Polyoxometalate nanomaterials for enhanced reactive oxygen species theranostics","volume":"472","author":"Liu","year":"2022","journal-title":"Coord. Chem. Rev."},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123596_bib33","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1007\/s12274-018-2092-y","article-title":"Scavenging of reactive oxygen and nitrogen species with nanomaterials","volume":"11","author":"Ferreira","year":"2018","journal-title":"Nano Res."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123596_bib34","article-title":"Reactive oxygen species-regulating strategies based on nanomaterials for disease treatment","volume":"8","author":"Zhang","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biomaterials.2025.123596_bib35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.progpolymsci.2018.08.005","article-title":"Natural polyphenols as versatile platforms for material engineering and surface functionalization","volume":"87","author":"Xu","year":"2018","journal-title":"Prog. Polym. Sci."},{"issue":"18","key":"10.1016\/j.biomaterials.2025.123596_bib36","doi-asserted-by":"crossref","first-page":"18562","DOI":"10.1021\/acsnano.3c06991","article-title":"Robust and multifunctional nanoparticles assembled from natural polyphenols and metformin for efficient spinal cord regeneration","volume":"17","author":"Yuan","year":"2023","journal-title":"ACS Nano"},{"issue":"46","key":"10.1016\/j.biomaterials.2025.123596_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202404815","article-title":"Natural polyphenol delivered methylprednisolone achieve targeted enrichment for acute spinal cord injury therapy","volume":"20","author":"Yuan","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2025.123596_bib38","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.progpolymsci.2017.09.003","article-title":"Versatile types of hydroxyl-rich polycationic systems via O-heterocyclic ring-opening reactions: from strategic design to nucleic acid delivery applications","volume":"78","author":"Xu","year":"2018","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.biomaterials.2025.123596_bib39","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41586-018-0622-0","article-title":"A metabolite-derived protein modification integrates glycolysis with KEAP1-NRF2 signalling","volume":"562","author":"Bollong","year":"2018","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123596_bib40","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.celrep.2019.06.047","article-title":"Molecular mechanism of cellular oxidative stress sensing by Keap1","volume":"28","author":"Suzuki","year":"2019","journal-title":"Cell Rep."},{"issue":"20","key":"10.1016\/j.biomaterials.2025.123596_bib41","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2300763120","article-title":"S-lactoyl modification of KEAP1 by a reactive glycolytic metabolite activates NRF2 signaling","volume":"120","author":"Ko","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA."},{"issue":"34","key":"10.1016\/j.biomaterials.2025.123596_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202400995","article-title":"Defining new benchmarks of low CTAB-concentration-based gold nanorod synthesis: the underestimated potential of polymer-directed anisotropic growth","volume":"34","author":"Lemich","year":"2024","journal-title":"Adv. Funct. Mater."},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123596_bib43","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1021\/acs.accounts.3c00101","article-title":"Surfactant layers on gold nanorods","volume":"56","author":"Mosquera","year":"2023","journal-title":"Acc. Chem. Res."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123596_bib44","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jconrel.2006.06.017","article-title":"PEG-modified gold nanorods with a stealth character for in vivo applications","volume":"114","author":"Niidome","year":"2006","journal-title":"J. Contr. Release"},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123596_bib45","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41581-023-00758-1","article-title":"Designing acute kidney injury clinical trials","volume":"20","author":"Zarbock","year":"2024","journal-title":"Nat. Rev. Nephrol."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123596_bib46","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nbt0510-436","article-title":"Next-generation biomarkers for detecting kidney toxicity","volume":"28","author":"Bonventre","year":"2010","journal-title":"Nat. Biotechnol."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225005150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225005150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T13:56:05Z","timestamp":1779717365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961225005150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":46,"alternative-id":["S0142961225005150"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123596","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydroxyl-augmented gold nanorods via lactone ring-opening alleviate cisplatin nephrotoxicity through Nrf2 activation","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123596","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123596"}}